Latest News

Boldyn Networks named a Major Player in IDC MarketScape for European Enterprise Private 5G Solutions

LONDON, July 3, 2025 /PRNewswire/ -- Boldyn Networks  (Boldyn), a global leader in private networks and shared communications infrastructure, has been recognised as aMajor Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment (doc ...

2025-07-03 21:17 2020

Chinese investors offered an index analytics tool, for free

ChinaAMC's CEO says the company aims to convert its asset allocation expertise into a simple solution BEIJING, July 3, 2025 /PRNewswire/ -- China's index investors are offered a powerful index analytics tool free of charge, after China Asset Management(referred as ChinaAMC below) released its up...

2025-07-03 21:16 2538

TCL Unveils D2 Pro Palm Vein Smart Lock with 0.3-Second Unlocking--Open 'Like Iron Man' to Redefine Home Security

Three–model D2 Series Debuts with AI–powered Local Storage and Versatile Smart Features NEW YORK, July 3, 2025 /PRNewswire/ -- Global smart–home leader TCL today launches its all–new D2 Series Smart Locks, headlined by the flagship TCL D2 Pro Palm Vein Smart Lock. Building on the remarkable succ...

2025-07-03 21:00 2488

TINECO LEADS CHARGE IN SMART FLOOR WASHING WITH BREAKTHROUGH TECH AND GLOBAL MOMENTUM

With Smart Innovation and Everyday Utility, Tineco's Best-in-Class Floor Washers Are Changing How the World Cleans SEATTLE, July 3, 2025 /PRNewswire/ -- Tineco, the global leader in smart floor care, is redefining the way people clean with its breakthrough floor washer portfolio– a smarter, easi...

2025-07-03 20:43 2109

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results

JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines inChina, toda...

2025-07-03 20:30 4743

Beat the Heat: Pigenius' New Sunshade Guide Helps Drivers Stay Cool This Summer

LOS ANGELES, July 3, 2025 /PRNewswire/ -- When it comes to protecting car owners and cars from the scorching sun, a high-quality sunshade is the essential accessory. For 30 years, Pigenius has focused solely on car sunshades, committed to protecting vehicle interiors and enhancing driving comfor...

2025-07-03 20:03 2357

NUS researchers develop novel material for water quality monitoring device

Introducing ReSURF sensor – an ultrafast, stretchable, self-healing and recyclable sensing device that enables on-site, real-time surveillance of water quality within milliseconds SINGAPORE, July 3, 2025 /PRNewswire/ -- Clean, safe water is vital for human health and well-being. It also plays a ...

2025-07-03 19:41 4904

Fangzhou Tops China's App Store Chart for Healthcare Apps

GUANGZHOU, China, July 3, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, earned the top spot in theJune 2025 China AppStore Healthcare TOP100 Free APP Rankings with its Fangzhou Online Pharmacy App, according to a report by ...

2025-07-03 18:43 2348

Beyond Boundaries: Envision's Record 49-Hour Fire Test Breaks New Ground in Energy Storage Safety

SHANGHAI, July 3, 2025 /PRNewswire/ -- Envision Energy, a global leader in green technology, has successfully completed a groundbreaking large-scale fire test for its smart energy storage system, raising the bar for safety, environmental responsibility, and system resilience. Conducted under full...

2025-07-03 18:33 2176

Yunji Announces Changes in Management

HANGZHOU, China, July 3, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that Mr.Yeqing Cui, has resigned as Senior Financial Director and finance in charge of the Company for personal reasons, effecti...

2025-07-03 18:30 2266

MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform

BOSTON, July 3, 2025 /PRNewswire/ -- MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment ofMaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer. The move comes as MOTE accelerates development of its MOBILIZ...

2025-07-03 18:07 2315

So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, July 3, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that it has received a written compliance notification f...

2025-07-03 17:00 4268

Modlily Launches "Summer of Self-Love" BOGO Campaign, Celebrating Confidence Through Fashion

LOS ANGELES, July 2, 2025 /PRNewswire/ -- International women's fashion brand Modlily—known for affordable, body-positive apparel—today launched its seasonal "Summer of Self-Love" Buy One, Get One (BOGO) Free promotion. From  July 1 through July 20, customers can refresh their summer wardrobes wit...

2025-07-03 15:54 2192

Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy

HONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's first bispec...

2025-07-03 14:46 2493

Andrés Iniesta, ambassador of fair play with MelBet

MADRID, July 3, 2025 /PRNewswire/ -- International company MelBet has announced a partnership with one of the best midfielders in football history – Barcelona legend, World Cup winner and two-time European champion Andrés Iniesta. The foundation for a productive partnership is the parties' desire...

2025-07-03 14:00 2747

Wei Zhou Named Among Caijing Magazine's Top 50 Global Chinese Venture Capitalists

PALO ALTO, Calif., July 3, 2025 /PRNewswire/ -- Recently, the prestigious media platform Caijing Magazine officially unveiled its "Top 50 Global Chinese Venture Capitalists" list.Wei Zhou, Founding Managing Partner of Cyber Creation Ventures (CCV), earned a coveted spot on the list thanks to his ...

2025-07-03 12:07 2893

MiniTool Released Video Converter 4.3 with New Features

VANCOUVER, BC, July 2, 2025 /PRNewswire/ -- MiniTool Software Limited has released a new version of its video conversion tool – MiniTool Video Converter 4.3. This update brings a new video compression feature and optimizes the interface. Upgrade Highlights in MiniTool Video Converter 4.3 * ...

2025-07-03 09:53 2088

Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

* ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR  exon20ins * Approval follows the U.S. FDA's Priority Review and is supported by the pivotal WU-KONG1 Part B study, in which ZEGFROVY demonstrated statistically significant and clinically meaningfulbenefits to patien...

2025-07-03 08:08 2372

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Highlights: * Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement * Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing da...

2025-07-03 07:09 2739

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

-  First participants with obesity or overweight with at least one weight-r elatedcomorbidity have been dosed in a U.S. 13-week Phase IIa study of small m oleculeoral GLP-1 receptor agonist ASC30. -  ASC30 oral once-daily tablet demonstrated up to 6.5% placebo-adjusted mean  body weight reduction f...

2025-07-03 07:00 2312